Detail akcie Electromed online

Business Summary: Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Financial Summary: BRIEF: For the three months ended 30 September 2025, Electromed Inc revenues increased 15% to $16.9M. Net income increased 45% to $2.1M. Revenues reflect Home Care-Medicare segment increase of 19% to $5.7M, Hospital segment increase of 52% to $1M. Basic Earnings per Share excluding Extraordinary Items increased from $0.17 to $0.26.